导管消融治疗持续性心房颤动伴左室功能不全的临床评价Effect of catheter ablation for persistent atrial fibrillation in patients with left ventricular dysfunction
孙育民,刘旭,王骏,王新华,施海峰,吴卫华,陆静,周立,顾佳宁,董佳霖,方唯一
摘要(Abstract):
目的评价导管消融治疗持续性心房颤动(房颤)伴左室功能不全的安全性以及临床疗效。方法心力衰竭(心衰)组为30例持续性房颤伴症状性左室功能不全(左室射血分数≤0.45)患者,对照组为年龄、性别、左房大小和房颤持续时间相匹配的60例无心衰的持续性房颤患者,均接受环肺静脉电隔离联合心房碎裂电位消融治疗房颤。比较两组导管消融手术相关参数及严重并发症发生率。对心衰组术前、术后的左房大小、左室功能及内径进行比较。结果两组病例均完成导管消融术,肺静脉隔离率分别为96.67%及98.33%(P=1.00)。两组间消融时间、X线透视时间和严重并发症发生率差异无统计学意义(202.23±39.03 min比201.87±36.80 min,P=0.97;26.80±7.77 min比27.06±7.16 min,P=0.88;3.3%比3.4%,P=1.00)。随访11±1个月,73%的心衰组患者和78%对照组患者维持窦性心律(P=0.61),两组中分别有40%和42%患者接受再次消融。与术前相比,术后9个月心衰组患者的左室射血分数增加了7.87%±4.72%,左房内径缩小3.77±4.02 mm,左室舒张末期内径减小6.87±5.32 mm,左室收缩末期内径减小8.93±7.60 mm(P均<0.05);维持窦性心律者心功能改善程度高于未能维持窦性心律者。结论包括器质性心脏病者在内,对于持续性房颤合并左室功能不全的患者,环肺静脉电隔离联合心房碎裂电位消融的并发症发生率及消融成功率与无左室功能不全的患者相似。房颤合并左室功能不全的患者经导管消融治疗后,左房、室扩大程度减轻,左室射血分数可得到显著提高。
关键词(KeyWords): 心房颤动;心力衰竭,充血性;导管消融术;肺静脉
基金项目(Foundation):
作者(Author): 孙育民,刘旭,王骏,王新华,施海峰,吴卫华,陆静,周立,顾佳宁,董佳霖,方唯一
参考文献(References):
- [1]孙育民,刘旭,王新华,等.导管消融治疗持续性心房颤动伴左室功能不全的初步随访.中国介入心脏病学杂志,2007,15:207-209.
- [2]Wang XH,Liu X,Sun YM,et al.Early identification and treat-ment of PVre-connections:role of observation time and impact onclinical results of atrial fibrillation ablation.Europace,2007,9:481-486.
- [3]王新华,刘旭,顾佳宁,等.环肺静脉消融电隔离治疗持续性心房颤动的疗效观察.中国介入心脏病学杂志,2006,14:147-151.
- [4]施海峰,刘旭,王新华,等.导管消融治疗慢性心房颤动两种消融策略对比研究.中国介入心脏病学杂志,2007,15:133-138.
- [5]施海峰,刘旭.环肺静脉前庭电隔离术后快速性房性心律失常的发生及处理.中国心脏起搏与心电生理杂志,2007,21:269-271.
- [6]Fuster V,Rydén LE,Cannom DS,et al.ACC/AHA/ESC 2006Guidelines for the Management of Patients with Atrial Fibrilla-tion:a report of the American College of Cardiology/AmericanHeart Association Task Force on Practice Guidelines and the Eu-ropean Society of Cardiology Committee for Practice Guidelines(Writing Committee to Revise the 2001 Guidelines for the Man-agement of Patients With Atrial Fibrillation):developed in col-laboration with the European Heart Rhythm Association and theHeart Rhythm Society.Circulation,2006,114:e257-354.
- [7]Chen MS,Marrouche NF,Khaykin Y,et al.Pulmonary vein i-solation for the treatment of atrial fibrillation in patients with im-paired systolic function.J Am Coll Cardiol,2004,43:1004-1009.
- [8]Hsu LF,Ja s P,Sanders P,et al.Catheter ablation for atrial fi-brillation in congestive heart failure.N Engl J Med,2004,351:2373-2383.
- [9]Tondo C,Mantica M,Russo G,et al.Pulmonary vein vestibuleablation for the control of atrial fibrillation in patients with im-paired left ventricular function.Pacing Clin Electrophysiol,2006,29:962-970.
- [10]Gentlesk P,Saner WH,Gerstenfeld EP,et al.Reversal of LeftVentricular Dysfunction Following Ablation of Atrial Fibrillation.J Cardiovasc Electrophysiol,2007,18:9-14.
- [11]Yarlagadda RK,Iwai S,Stein KM,et al.Reversal of cardiomy-opathy in patients with repetitive monomorphic ventricular ectopyoriginating from the right ventricular outflow tract.Circulation,2005,112:1092-1197.
- [12]Cappato R,Calkins H,Chen SH,et al.Worldwide survey onmethods,efficacy and safety of catheter ablation for human atrialfibrillation.Circulation,2005,111:1100-1105.
- [13]Bertaglia E,Zoppo F,Tondo C,et al.Early complications ofpulmonary vein catheter ablation for atrial fibrillation:A multi-center prospective registry on procedural safety.Heart Rhythm,2007,4:1265-1271.